DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will release its second-quarter financial results, for the period ended June 30, 2021, on Aug. 16, 2021. In conjunction with the release of its financial report, the company will also host a conference call and webcast, scheduled for the same day, to begin 8:30 a.m. ET. Company executives Erez Raphael, CEO, and Rick Anderson, president and general manager of North America, will host the call, along with Zvi Ben-David, chief financial officer. Those interested in participating can call 877-451-6152; international callers can dial 201-389-0879. Participants should reference “DarioHealth Second Quarter 2021 Results Call” as the conference ID and are encouraged to dial in at least 10 minutes before the call to ensure access. Interested participants can also view a live webcast. A replay of the call will be available through Sept. 16, 2021, and can be accessed by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and entering replay passcode 13722168.
To view the live webcast, visit https://ibn.fm/QNHuI
To view the full press release, visit https://ibn.fm/4SV8h
About DarioHealth Corp.
DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market, covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions; intuitive, clinically proven digital tools; high-quality software; and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology, utilizing a performance-based approach to improve users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.